Tissue Repair
Darryl Reed serves as the Chief Operating Officer at Tissue Repair Ltd, a clinical stage biopharmaceutical company focused on advanced wound healing technology since June 2021. Previously, Darryl held the position of National Sales Lead at Alexion Pharmaceuticals, overseeing a team of Regional Account Managers and driving sales strategies. As the Founder and Director of DSTM Pharma Pty Ltd from March 2019 to March 2020, Darryl established the company's vision and engaged with investors. Earlier roles include National Business Manager at Bayer Pharmaceuticals, managing healthcare professional sales teams and brand strategies, and Medical Affairs Manager at Roche. Darryl began a career in research as a Postdoctoral Fellow at the Ludwig Institute for Cancer Research. Educational qualifications include a Master's in Business Management, a Master's in Medical Science, a Ph.D. in Biochemistry and Molecular Biology, and a Bachelor of Science with Honours in Genetics and Molecular Biology.
This person is not in any teams
Tissue Repair
Tissue Repair Ltd is an Australian biopharmaceutical company developing an advanced wound healing technology targeting applications in the chronic wound and cosmetic procedure markets. Tissue Repair has developed a unique active ingredient that is designed for wound healing and delivered topically. The biologically active pharmaceutical ingredient behaves like a decoy cell and simulates a yeast infection resulting in the stimulation of the body’s own wound repair pathways. This active ingredient also provides a platform for the opportunity to develop a range of products that have the potential to treat a broad range of conditions across the wound care market.